mRNA flu shots move into trials

Elie Dolgin • October 11, 2021

COVID-19 provided an opportunity to show that mRNA vaccines can work. Now, drug companies are racing to apply the technology platform for influenza.

Hot off the successful deployment of mRNA vaccines for the prevention of COVID-19, three leading drugmakers have moved seasonal flu vaccine candidates built with the technology into early clinical testing.


Continue reading at Nature Reviews Drug Discovery.

Clock face, DNA strand and assortment of animals: dolphins, deer, bears, whale, baboon
By Elie Dolgin September 22, 2025
Molecular signatures of aging are changing how conservationists assess population health, resilience and risk.
Yellow rings of DNA amidst white chromosomes
By Elie Dolgin September 11, 2025
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.